IDEXX Laboratories, Inc.

BMV:IDXX * Stock Report

Market Cap: Mex$689.6b

IDEXX Laboratories Past Earnings Performance

Past criteria checks 4/6

IDEXX Laboratories has been growing earnings at an average annual rate of 13.1%, while the Medical Equipment industry saw earnings growing at 8.3% annually. Revenues have been growing at an average rate of 9.8% per year. IDEXX Laboratories's return on equity is 53.5%, and it has net margins of 22.5%.

Key information

13.1%

Earnings growth rate

13.9%

EPS growth rate

Medical Equipment Industry Growth12.9%
Revenue growth rate9.8%
Return on equity53.5%
Net Margin22.5%
Next Earnings Update03 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How IDEXX Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BMV:IDXX * Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 243,845866947214
30 Jun 243,785846934208
31 Mar 243,725867925199
31 Dec 233,661845902191
30 Sep 233,588823888183
30 Jun 233,514791877183
31 Mar 233,431699858259
31 Dec 223,367679851255
30 Sep 223,340670848257
30 Jun 223,309664840249
31 Mar 223,274735821164
31 Dec 213,215745796161
30 Sep 213,135757770154
30 Jun 213,047728777152
31 Mar 212,858674739146
31 Dec 202,707582735141
30 Sep 202,591497717138
30 Jun 202,475460674134
31 Mar 202,457437681135
31 Dec 192,407428669133
30 Sep 192,351423657128
30 Jun 192,291407642123
31 Mar 192,252390638120
31 Dec 182,213377632118
30 Sep 182,170330621117
30 Jun 182,117307610115
31 Mar 182,045284596112
31 Dec 171,969263575109
30 Sep 171,906277561106
30 Jun 171,862263547104
31 Mar 171,820245534102
31 Dec 161,775222522101
30 Sep 161,732214516101
30 Jun 161,690202502100
31 Mar 161,63719249399
31 Dec 151,602192482100
30 Sep 151,55417447599
30 Jun 151,53118246799
31 Mar 151,508182457100
31 Dec 141,48618244898
30 Sep 141,48819943596
30 Jun 141,44319342293
31 Mar 141,40519040989

Quality Earnings: IDXX * has high quality earnings.

Growing Profit Margin: IDXX *'s current net profit margins (22.5%) are lower than last year (22.9%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: IDXX *'s earnings have grown by 13.1% per year over the past 5 years.

Accelerating Growth: IDXX *'s earnings growth over the past year (5.3%) is below its 5-year average (13.1% per year).

Earnings vs Industry: IDXX * earnings growth over the past year (5.3%) exceeded the Medical Equipment industry 1.9%.


Return on Equity

High ROE: IDXX *'s Return on Equity (53.5%) is considered outstanding.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 10:21
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

IDEXX Laboratories, Inc. is covered by 31 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Daniel OwczarskiAvondale Partners
Ishan MajumdarBaptista Research
Balaji PrasadBarclays